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Introduction
Health state utility values can be obtained from multiple 
sources, including patients, carers, health professionals, and 
the community (see [1] for a detailed overview). Currently, 
health state value sets are usually obtained from members 
of the general public who attempt to imagine what the state 
would be like, mainly argued for on the basis that the general 
population are the payers of healthcare. However, it has also 
been argued that values should be obtained from patients, as 
they better understand what it is like to live in poorer health 
[2–4]. Of course, utility values can be obtained directly from 
people whether or not they are patients. Own health state 
valuation, such as the EQ-5D, can be used to estimate value 
sets for (generic) measures of health or to value a person’s 
state without a descriptive system. The former is a more 
recent development and is now being described in the litera-
ture as “experience-based utility values,” where respondents 
own current health state values are modelled against their 
self-reported EuroQOL five dimensions questionnaire (EQ-
5D) health state, e.g., which is used to estimate a value set 
for all health states described by the EQ-5D [4–7].
The aim of the paper was to critically examine issues 
in the elicitation and use of experience-based utility values 
or own health state values and to propose some potential 
ways forward. We critically examined a number of impor-
tant issues: whose values matter; why there is a difference 
between own and hypothetical values; how to measure own 
health state values; why to use own health state values. 
Finally, the paper examines other ways that experience can 
be taken into account, such as the use of informed general 
population preferences. This paper is based on the opinions 
of the authors and not a systematic review of the literature, 
though we draw on our knowledge of the literature.
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A clarification: Whose values and what to value?
There are two main considerations in this literature (Table 1): 
whose values and what to value. The debate has tended to 
focus on the first of these: whether to use patient or general 
public values. The second is whether the public should value 
their own state or some hypothetical state. Conventionally, 
health state classification systems such as the EQ-5D are val-
ued using a large valuation survey of the general population. 
Each respondent is asked to value several hypothetical health 
states, which are modelled using regression analysis to gener-
ate preference weights that enable estimation of a utility value 
for every health state defined by the classification system (cell 
1). An alternative approach is to ask patients to value their own 
current state, referred to as own health state valuation (cell 4). 
Patients have also been asked to value hypothetical states (cell 
2) and the recent growing interest in experience-based utility 
values (cell 3). Of course, patients are also members of the 
general public, and the strict public vs patient dichotomy is a 
false—albeit informative—one [8]. A typical study in cell 4 
usually has a relatively small, clinically homogeneous sample 
and therefore cannot elicit values for enough states to model 
the entire descriptive system. A study in cell 3 aims for a large, 
heterogeneous sample, with the aim to value all possible states 
in a descriptive system. However, the established literature 
compares cells 1 and 4 rather than 1 against 3. A third con-
sideration is whether to link values from any of these cells to 
a descriptive system, e.g., EQ-5D, which is a comparatively 
recent development in the literature. In common with much 
of the literature, the term patient is often used in this paper 
for simplicity to refer to experience-based values, though it 
is not that the person is a patient that matters per se but their 
experience of the state.
How to measure experience‑based utility?
The terminology originated with Kahneman [9], who distin-
guished between (stated) preference-based methods of valu-
ation, such as willingness to pay, standard gamble (SG), and 
time tradeoff (TTO), which elicit what he calls decision utility, 
and the hedonic and affective experiential methods associated 
with an outcome he calls experienced utility. He and others 
have questioned the validity of decision-utility-based meth-
ods due to systematic errors in forecasts of how we may feel 
in future states [10]. In its place, they argued for a return to 
an interpretation of utility used by Bentham, in which utility 
is the pleasure and pain experienced in each moment of time 
[11]. This would imply a return to measuring utility directly 
and in cardinal form from the person experiencing it and hence 
experienced utility [12].
Kahneman recommends measuring utility using moment-
based happiness [9]. The most direct method of doing so 
is the experienced sampling methodology’ [13] in which 
participants are contacted at multiple random points dur-
ing the day and asked about how they are feeling and how 
happy they are at each time point. A more pragmatic and 
less intrusive solution is the day reconstruction method [14], 
which asks people to recount different episodes of the pre-
vious day and how they felt during each episode. Data on 
affective experience from the previous day is then combined: 
one possibility is to take the difference between the average 
positive feelings (or the most intense positive) and the aver-
age negative (or the most intense negative) [14] and estimate 
an area under the plotted curve (AUC) to define experienced 
utility over time. Another possibility is to use the proportion 
of time in which the most intense negative affect outweighs 
the most intense positive, referred to as a U-index [15].
The methods for assessing experienced utility in the 
sense used by Kahneman are criticized by economists, as 
they do not require the respondent to make a sacrifice. In 
other words, there is no opportunity cost, so there are ques-
tions about the meaning behind the expression of feelings, 
whether they can be compared between individuals, and 
whether they provide cardinal values.
Kahneman’s use of the term experienced utility can be 
compared with direct utility assessment, or patient own 
health state valuation, in the health economics literature. 
Patients own health state values can be obtained using 
visual analog scales (VAS), which may be considered a 
proxy for current momentary experience, but where those 
values are based on TTO, SG, or another choice exercise, 
it is a preference expressed over hypothetical future expe-
rience and a measure of decision’ rather than experienced 
utility in the way Kahneman has coined the term. The use 
of choice-based methods such as TTO to elicit values for 
experience-based utility requires respondents to value their 
current state by imagining what it would be like to be in 
full health for a shorter number of years—a state they may 
not have experienced for many years. For people who have 
lived in a chronic health state, e.g., chronic obstructive pul-
monary disease or osteoarthritis, the task of imagining full 
health is potentially as difficult as a healthy member of the 
general population trying to imagine a poor health state. In 
addition, such individuals are being asked to imagine that 
they will remain in their current state for some specified 
period, such as 10 years in the case of the EQ-5D valua-
tion study by Burstrom et al. [7], and then to imagine dying 
after that period. This is a hypothetical task and raises issues 
about how realistic this would be for most respondents and 
Table 1  Categorizing values by population and what is valued
General public Patients
Hypothetical states Cell 1 Cell 2
Own current state Cell 3 Cell 4
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Kahneman’s question about people’s ability to predict their 
experienced utility into the future. Many concerns raised 
with the TTO task for hypothetical states are applicable to 
the TTO task for own health state valuation. For example, 
during the TTO task, do respondents really imagine their 
current health state will not change or do they imagine some 
change over time? Do they consider the fact they may adapt, 
that their life circumstances may change and so forth? Do 
they include more than the EQ-5D state they have just com-
pleted [e.g., their wider QoL (QoL), and if so, what else 
do they take into account? How do they deal with the idea 
of dying? SG addresses the concerns raised above with the 
addition that responses would also be impacted by respond-
ents’ attitude to and perception of risk. Currently, we do not 
know the impact of all of these factors, and there is a role 
for qualitative research to examine what is actually being 
valued with these tasks. However, what we can conclude is 
that own health state valuation using TTO or SG is not the 
same as experienced utility in the way Kahneman and col-
leagues describe it. For this reason, throughout the remain-
der of the paper, we refer to own health state valuation rather 
than experience-based utility.
VAS has the advantage that it can arguably be viewed 
as a proxy for current momentary experience and so avoid 
some of the problems associated with choice-based tasks. It 
also has the ability to measure the value of the person’s own 
state where this can incorporate a wider notion of QoL rather 
than simply health. However, there are well-documented 
problems with VAS [1], including the use of rounded num-
bers (such as 80, 85, 90) rather than using all points along 
the scale and that the value may not represent utility, as it 
involves no sacrifice or tradeoff. An additional complication 
is that the value is not anchored on the 1–0 full health–dead 
scale unless there is some consideration of value of the own 
health state relative to the value for dead.
Whose values matter
Chosing from whom to elicit values is important, because it 
may influence the resulting values. A number of empirical 
studies have been conducted that indicate that people with 
first-hand experience tend to (although not always) place 
higher values on dysfunctional health states than members of 
the general population who do not have similar experiences, 
and the extent of this discrepancy tends to be much stronger 
when people value their own health state [16–18]. However, 
there is some evidence suggesting that for mental health, 
values may be lower for people with experience of mental 
health problems [19] as, contrary to the general population, 
they tend to place a greater weight on mental health impair-
ments relative to physical health impairments [20]. However, 
this research was based on valuing hypothetical states and 
not on valuing own health.
Earlier empirical studies comparing patient and general 
population values tended to use relatively small sample sizes 
and focused on differences in patient and general popula-
tion values for a single medical condition or type of health 
problem. More recently, studies have attempted to use larger 
sample sizes across the general population or multiple patient 
samples, to compare across cells 1 and 4 of Table 1, and to 
collect large samples of data for cell 3. Mann et al. [5], e.g., 
estimated EQ-5D preference weights using regression analysis 
of own VAS data (cell 4) from patients diagnosed with eight 
different conditions (n = 3376) and compared results with 
EQ-5D preference weights estimated using regression analysis 
of hypothetical VAS values elicited from the general popu-
lation (cell 1) (n = 2997; the measuring and valuing health 
(MVH) data set [21]). Compared with the general population, 
model the decrements for anxiety/depression were statistically 
significantly larger in the patient model but smaller for pain/
discomfort and mobility. The magnitude of disagreement 
between the patient self-rated and the population VAS mod-
els was found to vary depending upon the patient’s condition. 
Rand-Hendriksen et al. [22] examined differences in the rela-
tive importance attributed to EQ-5D dimensions between own 
health state valuations from patients (n = 74,277) (cell 4) and 
hypothetical health valuations from the general population 
(n = 3773) (cell 1) for EQ-5D states using VAS in the United 
States. Self-care and pain/discomfort were the most important 
dimensions for the hypothetical health valuations, whereas 
usual activities was the most important dimension for own 
health state valuations. Little et al. [23] compared German 
own health state valuations (n = 2032, obtained from Leidl 
and Reitmeir [24]) and European hypothetical health valua-
tions from the general population (n = 6870) (cell 1 vs cell 
4) for EQ-5D using VAS, finding that pain/discomfort was 
the most important dimension for the own health state valu-
ations. Sun et al. [6] generated EQ-5D preference weights 
by modeling own VAS using Chinese experience-based data 
(n = 120,709) (cell 3) and showed anxiety/depression had the 
greatest impact on own VAS values.
Burstrom et al. [7] used TTO (along with VAS) to esti-
mate Swedish own health state value sets for EQ-5D-3L 
using general population health survey data (cell 3). A large 
sample (n = 45,000 individuals) was used to facilitate mod-
eling of own health state TTO and VAS values in terms 
of the EQ-5D descriptive system. They found the anxiety/
depression dimension had the greatest impact on both own 
TTO and VAS values.
In summary, although findings vary between these indi-
vidual studies in terms of relative impact of dimensions 
according to own health state valuation, the available evi-
dence highlights the potential for systematic differences 
between hypothetical general population preferences and 
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own health state values that could impact results of an eco-
nomic evaluation. The nature of this impact is examined.
Why is there a difference between own 
and hypothetical values?
There are a number of possible contributing factors for 
observed differences between patient and general population 
values. Earlier, we argued that respondents in poor health 
states may find it hard to imagine full health. The literature 
suggests additional possible explanations, including poor 
descriptions of health states (for the general population), use 
of different internal standards, and adaptation or response 
shift [1, 3]. These are discussed in detail below.
Poor descriptions of health states
An important potential source of discrepancy is found when 
descriptions provided to the general population in cell 1 may 
not accurately describe the health state, even when these are 
produced using a health state descriptive system. Respond-
ents can bring their own information to the valuation exer-
cise by drawing upon their own personal experiences or 
limited knowledge. Given that the personal experiences of 
people with a health condition and members of the gen-
eral public are unlikely to be the same, it may mean that, 
in effect, they are evaluating different health states, even 
when provided with identical descriptions of the state to 
be valued. For example, anxiety and depression can be dif-
ficult to imagine if you have never experienced them, and 
no further clarification is provided in the description of an 
EQ-5D state. Patient respondents in cell 4 will not necessar-
ily be valuing the health state they are categorized into by a 
descriptive system (like EQ-5D). Respondents are asked to 
value their current health state as they see it, and this may 
cover different dimensions to the measure being used. For 
example, there is some evidence that patients may interpret 
item response options differently: One patient with spinal 
cord injury answering a question on walking stated, “When 
I saw walking I just kind of took it as wheeling,” suggest-
ing that walking was interpreted as the ability to get about 
[25]. Furthermore, it has been suggested that general popula-
tion respondents in cell 1 focus too much on ill health and 
ignore the remaining positive aspects of a person’s life [3]. 
For example, the general population focusses on the negative 
aspects on a health state, whereas patients focus on both the 
positive and negative aspects [26].
Changing internal standards
A well-known phenomenon in the psychometric litera-
ture is response shift, which refers to the possibility that 
individuals will change their internal standards for evaluat-
ing their own health in response to changes in their health 
[27]. Response shift occurs due to changes in expectations. 
For example, an older person may rate his or her health 
according to their expectations of the best possible health 
for a person of their age rather than best possible health 
per se. Similarly, a patient may rate his or her health by 
comparing themselves with other patients rather than with 
healthy individuals. In either instance, response shift will 
contribute to discrepancies between patient and general 
population values in cells 1 and 4 for the same health states 
and, unlike the problem of incomplete or inaccurate health 
state descriptions, it is difficult to see how response shifts 
can be reduced or eliminated in practice. Indeed, it can be 
argued that response shift effects in health state valuation 
tasks conducted with patients should not be of concern, 
since these reflect aspects of adaptation and coping.
Adaptation to the state
Someone in a permanent and stable impaired health 
state is, depending on the health problem, likely to adapt 
over time, both physically and psychologically. Physical 
changes include acquisition of new skills to help cope with 
a disability, such as learning to use a walking stick. Or, a 
person may change the things they do to limit the impact 
of their disability or illness. For example, someone who 
once played football may take up a sport that has a lower 
impact on their knees. There are also psychological adap-
tations that include a shift in the relative weight that peo-
ple place on different aspects of health and QoL and, more 
fundamentally, a change in their view of what matters in 
life. In addition, people may lower their expectations of 
what they can achieve.
It is well established in the literature that people tend to 
underpredict their ability to adapt to physical health condi-
tions or impaired states [9, 28, 29]. When general population 
respondents read the description of a state, their valuation 
may reflect a response to, say, going blind, rather than being 
blind for an extended period. In other words, the general 
population focusses on the transition to the state rather than 
the longer-term consequences, and this results in the general 
population giving lower values compared with patient self-
reported values for chronic states of health. The implica-
tions of this are examined below. For further discussion of 
normative arguments around the use of values that take into 
account adaptation to inform resource allocation decisions, 
see [9, 28, 29].
These explanations for the differences in values between 
the general public imagining the state (cell 1) and respond-
ents valuing their own state (cell 4) may have implications, 
which are also examined below.
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How to collect own health state values
Asking respondents to value their own health state and 
to do so across a sufficiently wide range of health states 
of different types and severity raises two major practical 
problems. First, respondents in poor health states may be 
unable or unwilling to undertake complex and quite intru-
sive valuation tasks. This may be due to their physical 
limitations. Furthermore, there are also mental health and 
cognitive problems that make completing a health state 
valuation task (e.g., TTO) more challenging than simply 
completing the EQ-5D classification system, particularly 
if it is to be self-completed (which tends to be the case 
with many of these surveys). Furthermore, these tasks are 
completed only once by a respondent, without any assis-
tance from interviewers and without a practice question 
(which is difficult for own health valuation). Second, there 
will be ethical concerns with asking people in terminal 
or incurable conditions to imagine hypothetical scenarios 
involving return to full health, accompanied by either the 
risk of immediate death or shortening life. For this reason, 
it is not possible to ask some patient groups to complete 
health state valuation tasks for any state (hypothetical or 
own). Combined, these two practical problems will result 
in lower numbers in the poorer health states being sam-
pled, as shown by the low numbers reporting more severe 
levels of EQ-5D in Table 2 (taken from [6, 7]).
The data may also be suceptible to selection bias, since 
people experiencing a health state that has impacted more 
on their utility may not wish to participate in elicitation 
surveys (even if they are able to). The magnitude of this 
type of selection bias is likely to vary not only by the 
severity of the condition but also by dimension (e.g., men-
tal health). This will introduce a complex pattern of bias, 
with some (but not necessarily all) severe states having 
higher values than would be the case if it was a genuine 
random sample of people in those particular states. This 
may partly explain why own health state values are higher 
than the values of members of the general public imagin-
ing them. A major practical problem for the researcher 
is how to obtain a sample that is representative across 
the severity range. This is a survey design issue, and a 
different approach is proposed in below. Of course, it is 
also recognized that if some people in poorer health are 
less likely to participate in surveys, this impacts on the 
representativeness of results for both own state valuation 
surveys and surveys valuing hypothetical states. However, 
it could be argued that for evaluating hypothetical states, 
any impact would arguably be across all health states and 
would not be differential across different severity of states 
or across dimensions, meaning that for policy purposes, 
the incremental QALY change across interventions would 
not be expected to be impacted.
Econometric issues
The elicitation of own health state values for EQ-5D in the 
literature has involved the use of regression analyses of large 
general population samples who value their own health 
using TTO [7] or VAS [6, 22, 24] to produce preference 
weights for every health state defined by the classification 
system. Sample sizes for these studies were large: 49,169 
for Sweden [7], 74,277 for the USA [22], and 120,709 for 
China [6]. However, as these were general population sam-
ples, most respondents were in full or mild health states. 
Table 2 reproduces the distribution of (three-level) EQ-5D 
responses in the Swedish and Chinese samples used to esti-
mate preference weights for the EQ-5D based on own health 
state values. In both samples, the proportion of responses 
in level 1 in each dimension is large, and 39.8 and 87% of 
respondents are in EQ-5D full health in the Swedish and 
Chinese samples, respectively. However, the distribution for 
Sweden has larger proportions of respondents at levels 2 and 
3 for pain/discomfort and anxiety/depression dimensions.
The distribution of EQ-5D responses with most responses 
at level 1 and a small proportion of responses at the lowest 
level 3 means there is a large number of observations with 
TTO or VAS data for mild health states and only a small 
number for severe health states. This creates problems for 
modelling data to generate preference weights for every 
possible health state defined by the classification system. 
Even in the hypothetical health state valuation literature, it 
is usually not feasible to value all health states defined by 
a health state classification. Health states for hypothetical 
Table 2  Observed distribution of EuroQOL five dimensions ques-
tionnaire (EQ-5D) own health in surveys used to provide experience-
based utility data
EQ-5D dimension Level Sweden (%) 
(n = 46,169) [7]
China (%) 
(n = 120,709) 
[6]
Mobility 1 90.1 94.8
2 9.8 4.8
3 0.1 0.4
Self-care 1 98.4 96.8
2 1.2 2.8
3 0.4 0.4
Usual activities 1 91.2 95.2
2 7.7 4.0
3 1.1 0.8
Pain/discomfort 1 50.8 90.8
2 45.1 8.8
3 4.1 0.4
Anxiety/depression 1 66.5 93.6
2 30.8 6.0
3 2.7 0.4
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valuation are usually selected by design, such as an orthogo-
nal array (e.g., [30]), balance (e.g., [31]), or simulation of 
alternative selections (e.g., [32]. All of these approaches 
select health states to ensure that the model estimated using 
the preference data is able to produce preference weights 
with acceptable margins of error for every possible health 
state defined by the classification system, and thus selecting 
health states is an important component of any health state 
valuation study. However, the approach used in own health 
state valuation does not select health states in any systematic 
way. Also, it does not necessarily include any data on many 
of the health states, as 148 and 167 unique health states were 
observed in the Swedish and Chinese samples, respectively, 
out of the 243 possible EQ-5D states. It is likely that this will 
detrimentally impact on the accuracy of any model used to 
estimate values for every health state defined by the clas-
sification system.
It may be argued that while efficient designs aim to spread 
the prediction error across dimension levels and thus across 
states, own valuation data sets contain more data on pre-
cisely those states for which information it is needed, i.e., 
the most frequent states. At the extreme, there is no need to 
predict the value of health states that do not exist in the real 
world with the same (or even any) accuracy as those states 
that occur more often. However, states that drive the results 
of cost-effectiveness models may not be the ones that arise 
with sufficient frequency in a general population sample. 
Cost-effectiveness models are based on conditions and for 
different stages of disease progression across different treat-
ments, rather than EQ-5D health states per se, making it 
difficult to determine which EQ-5D health states are used in 
practice to estimate utility values for cost-effectiveness mod-
els across a wide range of patient groups and interventions.
A way forward: How could own valuation studies be 
designed?
An alternative approach to large-scale general-population 
own health state valuation surveys is to purposively sample 
people to provide own TTO values to ensure that values are 
obtained for health states that are informative for estimating 
a regression model estimating preference weights for every 
state described by the descriptive system. For example, a 
set of health states for, say, the EQ-5D-5L could be selected 
using a statistical design, and quotas could then be set for, 
say, 200 respondents in each health state and respondents 
from a sampling frame ensuring that respondents are repre-
sentative of that state in terms of sociodemographic charac-
teristics, such as age and gender (which usually will not be 
the same as for the general population).
To give an idea of the numbers involved, let us examine 
the numbers required in a general population survey using 
our experience from three online general population surveys. 
In the pool of 8600 respondents across the three surveys 
[33, 34], we observed 586 of 3125 unique EQ-5D-5L states 
broken down as follows: 11,111 had a 35% share, the next 
two states covered another 20% of respondents, and the next 
20 states covered another 30%. Only the top six states had 
an > 200. The 200th ranked state had just three observa-
tions. This would suggest that most EQ-5D-5L states (> 90% 
of them) have a prevalence rate of ≤ 0.02% in the general 
population. This suggests that to identify 200 individu-
als in a health state with a 0.02% prevalence, this would 
require screening one million individuals to find them (and 
not all of them may agree to be surveyed). There are many 
assumptions in this rough calculation that we would not care 
to defend, but a crucial one is that an online survey using 
self-completed health state valuation tasks of own states is 
likely to suffer from the biases raised earlier. To achieve 
representative samples in the more severe states requires 
more directed sampling strategies and different modes of 
administration to ensure the more disabled or dissatisfied 
are not excluded.
The advantage of taking a designed approach is that 
data would be informative for estimating regression coef-
ficients to produce weights for all health states defined by 
the descriptive system with acceptable levels of error, and 
values for these would be for own health, not hypothetical 
health, states. However, the challenges of finding people in 
more severe health states would be considerable, and the 
design would need to take into account the plausibility and 
prevalence of the more severe states selected in the study. 
Also note that such a sample that extensively oversampled 
respondents in low-prevalent states would no longer be a 
representative sample, where all members of the general 
public had an equal chance of being recruited.
Why use (or why not use) own health state values?
The original Washington Panel on the Cost Effectiveness 
in Health and Medicine, published in 1996 [35], advocated 
the use of general population values and argued that: “… 
the best articulation of society’s preferences for a particular 
state would be gathered from a representative sample of fully 
informed members of the community” (this has been reaf-
firmed for the reference case in the update [36]). The panel 
went on to use the notion of the veil of ignorance to sup-
port the use of community values, where: “a rational public 
decides what the best course of action is when blind to its 
own self-interest, where aggregating the utilities of persons 
who have no vested interest in particular health states seems 
most appropriate” [35]. Swedish guidelines for health tech-
nology assessment (HTA) from the Pharmaceutical Benefits 
Board state that utilities should be generated using patient 
values and own health state valuation: “Quality-adjusted 
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life-year (QALY) weightings should be based on methods 
such as the SG or TTO methods. QALY weightings based 
on appraisals of persons in the health condition in question 
are preferred before weightings calculated from an average 
of a population estimating a condition depicted for it” [37: 
p2]. However, many other international agencies providing 
guidelines for their preferred methods for HTA submis-
sions prefer hypothetical values elicited from the general 
population (Australia [38], Canada [39], France [40], The 
Netherlands [41, 42], Spain [43], UK (England and Wales 
[44], Scotland) [45]), though Australia, Canada, and Scot-
land accept own health state utility values (see [46] for an 
overview of international recommendations and regulations 
for utility data for HTA). People tend to compare themselves 
to peers with similar health problems, which will influence 
their own health state valuations. They argue that the values 
of different patient groups are not comparable, whereas a 
general population sample provides a coherent set of values.
A key argument is that the general population pays for the 
service. However, whereas members of the general popula-
tion may want to be involved in healthcare decision making, 
it is not clear that they want to be asked to value health states 
specifically (see, e.g., [47]). At the very least, it does not 
necessarily imply that the current practice of using relatively 
uninformed general population preferences is optimal. An 
argument for using own health state values is that people 
understand the impact of their health on their well-being 
better than someone trying to imagine it (although they are 
having to imagine full health in most health state valua-
tion tasks). Nevertheless, this does not necessarily imply 
that own health state values should be used on their own to 
inform resource allocation decisions. This requires a value 
judgement that society wants to incorporate all the changes 
and adaptations that occur in people who experience states 
of ill health over long periods of time. Some adaptation 
may be regarded as laudable, such as skill enhancement and 
activity adjustment, whereas cognitive denial of functional 
health, suppressed recognition of full health, and lowered 
expectations may be seen as less desirable [2]. Furthermore, 
there may be a concern that own health state values are con-
text based, reflecting comparisons with their recent experi-
ences of ill health and the health of their immediate peers 
[3], which relates to a response shift, as discussed above.
Alternative approaches
One conclusion from the above discussion is that it may be 
difficult to justify the exclusive use of own health state val-
ues or the currently widely adopted practice of using values 
from relatively uninformed members of the general popula-
tion. If it is accepted that, ultimately, the values of the gen-
eral population are required to inform resource allocation in 
a public system, it can be argued that respondents should be 
provided with more information on what the states are like 
for people experiencing them so they can provide informed 
values. There are many different ways of achieving this 
objective:
(1) Improve the descriptive systems, e.g., include well-
being dimensions that better reflect the impact on the 
lives of those experiencing the health states.
(2) Encourage more deliberation and reflection in the task.
(3) As in (2), but provide more information on adaptation 
or own health state values (e.g., through own TTO 
values for people in those health states) to the general 
population sample undertaking the valuations.
(4) Provide decision makers with two incremental cost-
effectiveness ratios or net benefit values using (a) gen-
eral population hypothetical values and (b) own health 
state values [4].
(5) Use subjective well-being to reweight an existing health 
state classification system, such as the EQ-5D [48].
Option 4 would add significantly to decision complexity 
and would imply the need for two threshold values. Unless 
the two analyses support the same decision, it further begs 
the question of how a decision maker decides which analysis 
or weights to use if they were to be combined. It could result 
in inconsistencies across decisions that would be difficult to 
defend, particularly when decisions are appealed in a court 
of law. We argue that it is better to agree on a single value 
set for decision making. Option 5 presents the challenge 
that results are not anchored onto the 1–0 full health–dead 
scale required to generate QALYs, as currently, no measures 
of subjective well-being have been valued using this scale. 
Below, we focus our discussion on options 1, 2, and 3.
Improving the descriptive system to take better account 
of the impact on well‑being
The description of health states used in valuation surveys 
relies on instruments like the EQ-5D, which covers the 
dimensions of mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression. This may be too narrow 
for some areas of health care [49] and does provides little 
information to general population respondents on the likely 
impact of these health problems on their lives. One solution 
to this problem is to develop a broader QoL measure, which 
describes the impact on functioning and well-being, and 
this option is being explored in the E-QALY project being 
undertaken by a number of the authors (JB, DR, TP, AT) 
[50]. This new generic measure may reduce the gap between 
general population hypothetical values and own valuations, 
since it provides a broader description of the impact of a 
health state.
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Encouraging more deliberation and reflection using 
conventional valuation methods
Encouraging more deliberation and reflection has been pro-
posed by a number of commentators on the subject [2, 3, 
28, 29, 51], and there are examples of some studies attempt-
ing to operationalize this in practice. A review of empirical 
studies attempting to inform general population respondents, 
published in 2009 and earlier, identified 14 studies reporting 
on methods used to elicit informed general population values 
for health states [52]. Interventions were categorized into the 
following: information to enrich health state descriptions 
(n = 7); simulation to reproduce symptoms of the health 
state (n = 2); opportunity to reflect and deliberate on health 
state descriptions (n = 2); exercises to evoke adaptation to 
the health state (n = 3). Most studies identified in the review 
attempted to generate informed general population values 
for health states by providing respondents with additional 
information using audio recordings and videos. These stud-
ies appear to show that general population values can be 
changed by providing additional data, though it is difficult 
to judge whether the population was better informed other 
than the finding that values were closer to patient values. For 
example, Clarke et al. [53] examined health state values for 
three Gaucher disease states by presenting information from 
patients currently living in the states. The authors used mul-
timedia equipment, finding no statistically significant dif-
ferences in utility between patients and general population 
samples. Cunningham and Hunt [54] used descriptions of 
dentofacial deformities and photographs of dental patients 
corresponding to the health state descriptions, again find-
ing no statistically significant differences in utility between 
patients and general population samples. Damschroder et al. 
[55] used an adaptation exercise when valuing states per-
taining to pre-existing and new-onset paraplegia, finding 
that completing an adaptation exercise statistically signifi-
cantly increased utility values. McTaggart-Cowan et al. [28] 
explored the extent to which members of the general popula-
tion changed their initial values for three rheumatoid arthritis 
states following an adaptation exercise; respondents listened 
to recordings of patients discussing how they adapted. After 
undergoing the adaptation exercise, respondents increased 
their values for rheumatoid arthritis states, and younger and 
healthier individuals were more likely to increase their initial 
values after being informed.
However, one study found that discussion of prefer-
ences elicited in a group setting did not have a statistically 
significant impact on responses. Stein et al. [56] used SG 
with a panel of 15 members of the general population who 
valued 41 different health states five times over the course 
of 6 months. Following initial individual valuations, the 
group was given the opportunity to discuss the health states, 
and following this discussion, individuals were given the 
opportunity to change their health state values, although 
with no reference to patient values or adaptation. Although 
no statistically significant differences were detected before 
and after the discussion, respondents indicated that the 
group discussion brought reassurance and cohesion to their 
responses.
Overall, this evidence suggests that informed general pop-
ulation preferences can reduce the difference between own 
health state values, though whether the values are therefore 
better informed is difficult to prove, and further research is 
encouraged [28, 57, 58]. The previous studies were con-
cerned with small numbers of mainly condition-specific 
states. It is not clear how practical these methods would 
be for valuing large numbers of generic states generated by 
measures such as the EQ-5D-5L. There is also concern that 
the impact on health state values would differ depending on 
the condition related to the underlying health state, adapta-
tion to that health state, and the impact of that condition. 
For example, the impact on health state values from adapta-
tion to problems with self-care may differ depending upon 
whether the problems were caused by rheumatoid arthritis, 
Parkinson’s disease, or stroke. One option is to not identify 
the condition but, instead, to widen the impact of the health 
state on wider QoL and non-health-related consequences, 
such as enjoyment, independence, relationships, and dig-
nity [59]. This is one option being explored by the authors 
through the development of a broader descriptive system 
(i.e., option 1 above).
Using citizens’ juries and MCDA
Citizens’ jury and multicriteria decision analysis (MCDA) 
can also be used to elicit informed utility values from the 
general population. However, as far as we are aware, they 
have not been used to value health states, and the meth-
ods may understandably need further consideration and 
adaptation to the context. A citizens’ jury involves a small 
sample of participants deliberating on a topic and reaching 
a democratic recommendation [60]. In the area of health 
policy, a sample of general population participants: (a) are 
presented with a health policy dilemma, (b) review and 
examine evidence on the dilemma, with the presentation of 
the evidence undertaken by experts, and (c) deliberate the 
dilemma to reach a consensus for a recommendation, which 
not all participants have to agree with [60]. Participants in 
a citizens’ jury are not typically expected to be informed 
prior to the process; rather, they become informed during 
the process. The National Institute for Health and Clinical 
Excellence (NICE) Citizens’ Council is an example of a citi-
zens’ jury that is routinely involved in health-policy decision 
making (though this is just one type of citizens’ jury). The 
outcome of the citizens’ jury is typically qualitative, mean-
ing that the strength of preference is not typically indicated. 
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Therefore, a citizens’ jury would need to be combined with 
one of the other techniques, such as TTO. This could involve 
participants undertaking TTO tasks “cold” before becom-
ing informed on the topic, undertaking the full deliberative 
process of the citizens’ jury, and then completing the same 
TTO survey again to provide informed responses (see, e.g., 
[61]). Undertaking the same TTO survey before and after the 
deliberative process enables the impact of the deliberative 
process to be assessed.
MCDA can be used to evaluate health states in a group 
setting by explicitly considering multiple criteria. This ena-
bles a structured approach as: 
(1) Criteria are determined
(2) Scores reflecting the value of how health states perform 
according to each multiple criteria item are determined
(3) Weights that reflect the relative importance of each dif-
ferent criterion are considered
(4) A recommendation is reached [62].
Different types of approaches can be used to score and 
weight criteria: value measurement models; outranking 
models; goal, aspiration, or reference-level models [62]. 
Scores and weights can be determined separately, e.g., using 
VAS; or scores and weights can be determined simultane-
ously, e.g., using discrete choice experiments or TTO (see 
[63]). This could be similar to recent work on “personal 
utility functions” undertaken by Shah et al. [64].
Conclusions
This paper has critically examined the recent interest in the 
use of experience-based utility and own health state valua-
tion for existing health state classification systems. We con-
clude that TTO and VAS tasks do not measure experience 
utility, as described by Kahneman and colleagues, and we 
refer to own health state valuation rather than experience-
based utility. The literature has reported on the collection of 
large amounts of quite complex data from people who may 
not be actually valuing what we imagine they are valuing 
and not providing values of health states across the sever-
ity range. Though arguments for eliciting own health state 
values require consideration, the suitability of current pref-
erence weights generated using own health state values for 
informing policy should be questioned.
We proposed one approach for collecting own health 
state values that would provide less biased data for model-
ling values to produce preference weights by systematically 
selecting health states and purposively sampling respondents 
using a sampling frame to meet predefined quotas. How-
ever, this does not address the issue that the valuation task 
would still most likely need to be self-completed only once, 
without any assistance from interviewers or a practice ques-
tion, which is likely to impact data quality. Other possible 
methods of eliciting own health state utility values that do 
not have these problems would be of great value. Finally, 
we suggested alternative approaches of obtaining more 
informed general population preferences that take more 
account of patient views and experience. This is a promis-
ing way forward that warrants further exploration.
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